{
  "slug": "zoetis-abaxis",
  "name": "zoetis-abaxis",
  "description": "Zoetis, a global animal health company, acquired Abaxis to integrate its leading point-of-care diagnostic instruments and consumables into a comprehensive portfolio that includes vaccines, parasiticides, anti-infectives, and other animal medicines for pets and livestock.",
  "url": "https://optimly.ai/brand/zoetis-abaxis",
  "websiteUrl": "https://zoetis-abaxis.com/",
  "logoUrl": "https://logo.clearbit.com/zoetis-abaxis.com",
  "baiScore": 52,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Animal Health",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:03:46.112Z",
  "verifiedVitals": {
    "website": "https://zoetis-abaxis.com",
    "founded": "2013",
    "headquarters": "Parsippany, New Jersey, USA",
    "pricing_model": "Primarily product sales (instruments, consumables, pharmaceuticals) with potential for recurring revenue from test kits, reagents, and service contracts.",
    "core_products": "Veterinary diagnostic instruments (e.g., VetScan analyzers), diagnostic tests, vaccines, parasiticides, anti-infectives, and other animal pharmaceuticals.",
    "key_differentiator": "A comprehensive, integrated portfolio spanning both advanced point-of-care diagnostics and a broad range of animal pharmaceuticals, supported by global reach and strong R&D capabilities.",
    "target_markets": "Veterinarians, livestock producers, pet owners (indirectly), and research institutions globally.",
    "employee_count": "Approximately 12,000+",
    "funding_stage": "Publicly Traded (NYSE: ZTS)",
    "subcategory": "Veterinary Diagnostics, Pharmaceuticals"
  },
  "intentTags": {
    "problemIntents": [
      "Traditional External Veterinary Lab Services: Veterinarians sending samples to third-party labs for analysis, which can be time-consuming, delay diagnosis, and require additional logistics compared to",
      "Symptomatic Treatment Without Advanced Diagnostics: Relying solely on clinical signs, history, and empirical treatment approaches without comprehensive diagnostic testing, which can lead to misdiagnos"
    ],
    "solutionIntents": [
      "Zoetis Abaxis diagnostics",
      "Zoetis animal health products",
      "Abaxis veterinary analyzers",
      "Zoetis stock price",
      "Abaxis human diagnostics",
      "Specialized Standalone Diagnostic Equipment: Purchasing individual diagnostic machines (e.g., hematology analyzer from one vendor, chemistry analyzer from another) from various niche manufacturers, le"
    ],
    "evaluationIntents": []
  },
  "businessProfileClaims": [],
  "timestamp": 1786603818906
}